Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Acad Emerg Med. 2015 Oct 15;22(11):1274–1282. doi: 10.1111/acem.12795

Table 3.

Contingency tables and classification performance of Serum GFAP in detecting traumatic intracranial lesions on head CT.

a. Isolated skull fractures excluded from intracranial lesions.

Table 3a. CT positive CT negative
GFAP positive >0.15 ng/ml 17 71
GFAP negative ≤0.15 ng/ml 1 63
Sensitivity 94% (71-100)
Specificity 47% (38-56)
NPV 98% (90-100)
PPV 19% (12-29)

b. Isolated skull fractures included with intracranial lesions.

Table 3b. CT positive CT negative

GFAP positive>0.15 ng/ml 20 68
GFAP negative ≤0.15 ng/ml 1 63
Sensitivity 95% (74-100)
Specificity 48% (39-56)
NPV 98% (90-100)
PPV 22% (15-33)

c. Patients presenting with a GCS 15.

Table 3c. CT positive CT negative

GFAP positive >0.15 ng/ml 14 60
GFAP negative ≤0.15 ng/ml 1 60
Sensitivity 93% (66-100)
Specificity 50% (41-59)
NPV 98% (90-100)
PPV 19% (11-30)

CT = computed tomography; GFAP = glial fibrillary acidic protein; NPV = negative predictive value; PPV = positive predictive value